Close Menu

IT

The company hopes to help consumer genomics firms and healthcare companies reduce the IT burdens associated with launching a new test.

BioEnterprise's Midwest Health Care Venture Investment Report showed a total 47 companies raising a combined $155.6 million during the first quarter of 2009, compared with 14 companies winning $133.5 million in the year-ago period.

Some of NIH's and NHGRI's challenge grants will give priorities to ethical issues that confront genomics, pharmacogenomics, and biomedicine.

Paired Ends: Apr 7, 2009

Premium

Helaman Escobar, John Keilty, Lutz Kirchrath

The Northwest Association for Biomedical Research has received a three year, $1.3 million grant from the National Science Foundation to support its education outreach programs.

Looking to support local industry and nurture Ireland's economic recovery, University College Dublin and Trinity College Dublin will combine their existing programs in tech transfer, enterprise development, industry relations, and post-graduate entrepreneurial education, largely in the area of life sciences.

The company will use the Expressionist and Phylosopher software in its search for transplantation and autoimmune biomarkers.

Pfizer La Jolla Incubator, Chromocell, NJEDA Biotechnology Development Center, Wockhardt USA LLC, Acorda Therapeutics, Eastman Business Park, Qatar Science & Technology Park, and more…

Kevin Conroy has been named the new president and CEO of Exact Sciences, while Don St. Pierre is serving as the acting director of FDA's Office of In Vitro Diagnostics, plus more.

Pages

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.